Although internet-based surveillance methods have recently been established to enhance vector-borne disease surveillance, assessment of their utility is required to determine how best to position this technology to improve infectious disease outcomes.
While immunocompromised patients are the most susceptible to CNS fungal infections, they can also occur in immunocompetent patients undergoing invasive procedures such as neurosurgery and in patients exposed to contaminated devices or drugs.
Although substantial emphasis is placed on vaccinations in considering how to limit the spread of influenza, simple hygienic methods have been found to be the most effective and should be more widely supported.
The potential role of vaccinations in combatting antimicrobial resistance (AMR) is currently undervalued. The distribution and development of new vaccines should be priorities in efforts to address the AMR crisis.
Despite worse outcomes in older adults, treatment efficacy and safety of direct-acting antivirals appear to be similar between older adults and younger patients, based on limited available data. Age should not be considered a barrier to treatment in older HCV-infected adults.
The goal of ART in neonates has expanded from reducing morbidity and mortality to the possibility of facilitating remission, but further research is needed to advance this goal, and additional treatment options are also needed for this population.